Literature DB >> 26942423

Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.

Ya Hui Hung1, Mark Walterfang1,2, Leonid Churilov3,4, Lisa Bray1, Laura H Jacobson5, Kevin J Barnham5,6,7, Nigel C Jones8, Terence J O'Brien8, Dennis Velakoulis2, Ashley I Bush9.   

Abstract

Autosomal recessive inheritance of NPC1 with loss-of-function mutations underlies Niemann-Pick disease, type C1 (NP-C1), a lysosomal storage disorder with progressive neurodegeneration. It is uncertain from limited biochemical studies and patient case reports whether NPC1 haploinsufficiency can cause a partial NP-C1 phenotype in carriers. In the present study, we examined this possibility in heterozygotes of a natural loss-of-function mutant Npc1 mouse model. We found partial motor dysfunction and increased anxiety-like behavior in Npc1 (+/-) mice by 9 weeks of age. Relative to Npc1 (+/+) mice, Npc1 (+/-) mice failed to show neurodevelopmental improvements in motor coordination and balance on an accelerating Rotarod. In the open-field test, Npc1 (+/-) mice showed an intermediate phenotype in spontaneous locomotor activity compared with Npc1 (+/+) and Npc1 (-/-) mice, as well as decreased center tendency. Together with increased stride length under anxiogenic conditions on the DigiGait treadmill, these findings are consistent with heightened anxiety. Our findings indicate that pathogenic NPC1 allele carriers, who represent about 0.66 % of humans, could be vulnerable to motor and anxiety disorders.

Entities:  

Keywords:  Carrier; Heterozygote disease; NPC1; Neurological; Niemann–Pick disease type C; haploinsufficiency

Mesh:

Substances:

Year:  2016        PMID: 26942423      PMCID: PMC4965399          DOI: 10.1007/s13311-016-0427-5

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  41 in total

1.  Laboratory review: the role of gait analysis in seniors' mobility and fall prevention.

Authors:  Stephanie A Bridenbaugh; Reto W Kressig
Journal:  Gerontology       Date:  2010-10-27       Impact factor: 5.140

2.  Evaluation of gait impairment in mice subjected to craniotomy and traumatic brain injury.

Authors:  M Sashindranath; M Daglas; R L Medcalf
Journal:  Behav Brain Res       Date:  2015-02-23       Impact factor: 3.332

3.  Heterozygous Niemann-Pick disease type C presenting with tremor.

Authors:  Keith A Josephs; Joseph Y Matsumoto; Noralane M Lindor
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

4.  Neurofibrillary tangles in Niemann-Pick disease type C.

Authors:  S Love; L R Bridges; C P Case
Journal:  Brain       Date:  1995-02       Impact factor: 13.501

5.  Neurodegeneration in heterozygous Niemann-Pick type C1 (NPC1) mouse: implication of heterozygous NPC1 mutations being a risk for tauopathy.

Authors:  Wenxin Yu; Mihee Ko; Katsuhiko Yanagisawa; Makoto Michikawa
Journal:  J Biol Chem       Date:  2005-05-25       Impact factor: 5.157

6.  Type C Niemann-Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts.

Authors:  H S Kruth; M E Comly; J D Butler; M T Vanier; J K Fink; D A Wenger; S Patel; P G Pentchev
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

7.  Parkinsonism syndrome in heterozygotes for Niemann-Pick C1.

Authors:  Hans H Kluenemann; John G Nutt; Marie Y Davis; Thomas D Bird
Journal:  J Neurol Sci       Date:  2013-09-03       Impact factor: 3.181

8.  Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations.

Authors:  David Meyre; Jérôme Delplanque; Jean-Claude Chèvre; Cécile Lecoeur; Stéphane Lobbens; Sophie Gallina; Emmanuelle Durand; Vincent Vatin; Franck Degraeve; Christine Proença; Stefan Gaget; Antje Körner; Peter Kovacs; Wieland Kiess; Jean Tichet; Michel Marre; Anna-Liisa Hartikainen; Fritz Horber; Natascha Potoczna; Serge Hercberg; Claire Levy-Marchal; François Pattou; Barbara Heude; Maithé Tauber; Mark I McCarthy; Alexandra I F Blakemore; Alexandre Montpetit; Constantin Polychronakos; Jacques Weill; Lachlan J M Coin; Julian Asher; Paul Elliott; Marjo-Riitta Järvelin; Sophie Visvikis-Siest; Beverley Balkau; Rob Sladek; David Balding; Andrew Walley; Christian Dina; Philippe Froguel
Journal:  Nat Genet       Date:  2009-01-18       Impact factor: 38.330

9.  Disease and patient characteristics in NP-C patients: findings from an international disease registry.

Authors:  Marc C Patterson; Eugen Mengel; Frits A Wijburg; Audrey Muller; Barbara Schwierin; Harir Drevon; Marie T Vanier; Mercé Pineda
Journal:  Orphanet J Rare Dis       Date:  2013-01-16       Impact factor: 4.123

10.  High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets.

Authors:  Christopher A Wassif; Joanna L Cross; James Iben; Luis Sanchez-Pulido; Antony Cougnoux; Frances M Platt; Daniel S Ory; Chris P Ponting; Joan E Bailey-Wilson; Leslie G Biesecker; Forbes D Porter
Journal:  Genet Med       Date:  2015-03-12       Impact factor: 8.822

View more
  8 in total

1.  Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C.

Authors:  Alberto Benussi; Maria Sofia Cotelli; Maura Cosseddu; Valeria Bertasi; Marinella Turla; Ettore Salsano; Andrea Dardis; Alessandro Padovani; Barbara Borroni
Journal:  JIMD Rep       Date:  2017-01-17

Review 2.  The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity.

Authors:  Amel Lamri; Marie Pigeyre; William S Garver; David Meyre
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

Review 3.  Current concepts in the neuropathogenesis of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Steven U Walkley
Journal:  J Neurochem       Date:  2018-08-30       Impact factor: 5.372

Review 4.  Do GWAS and studies of heterozygotes for NPC1 and/or NPC2 explain why NPC disease cases are so rare?

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2018-09-13       Impact factor: 3.240

5.  Gene Therapy in a Mouse Model of Niemann-Pick Disease Type C1.

Authors:  Yoshie Kurokawa; Hitoshi Osaka; Takeshi Kouga; Eriko Jimbo; Kazuhiro Muramatsu; Sachie Nakamura; Yuki Takayanagi; Tatsushi Onaka; Shin-Ichi Muramatsu; Takanori Yamagata
Journal:  Hum Gene Ther       Date:  2021-02-22       Impact factor: 5.695

6.  Neurotoxic effects of nephrotoxic compound diethylene glycol.

Authors:  Courtney N Jamison; Robert D Dayton; Brian Latimer; Mary P McKinney; Hannah G Mitchell; Kenneth E McMartin
Journal:  Clin Toxicol (Phila)       Date:  2021-01-21       Impact factor: 3.738

7.  Clinical delineation of 18q11-q12 microdeletion: Intellectual disability, speech and behavioral disorders, and conotruncal heart defects.

Authors:  Kitiwan Rojnueangnit; Chariyawan Charalsawadi; Weerin Thammachote; Ariya Pradabmuksiri; Thipwimol Tim-Aroon; Antonio Novelli; Sara Loddo; Silvana Briuglia; Cutrupi M Concetta; Duangrurdee Wattanasirichaigoon; Natini Jinawath
Journal:  Mol Genet Genomic Med       Date:  2019-08-07       Impact factor: 2.183

8.  Age-related Loss of miR-124 Causes Cognitive Deficits via Derepressing RyR3 Expression.

Authors:  Kai Liu; Yongjia Yin; Yuan Le; Wen Ouyang; Aihua Pan; Jufang Huang; Zhongcong Xie; Qubo Zhu; Jianbin Tong
Journal:  Aging Dis       Date:  2022-10-01       Impact factor: 9.968

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.